{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:07:17Z","timestamp":1792642037322,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG045656"],"award-info":[{"award-number":["AG045656"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease (HD) is caused by Huntingtin (Htt) gene mutation resulting in the loss of striatal GABAergic neurons and motor functional deficits. We report here an in vivo cell conversion technology to reprogram striatal astrocytes into GABAergic neurons in both R6\/2 and YAC128 HD mouse models through AAV-mediated ectopic expression of NeuroD1 and Dlx2 transcription factors. We found that the astrocyte-to-neuron (AtN) conversion rate reached 80% in the striatum and &gt;50% of the converted neurons were DARPP32\n                    <jats:sup>+<\/jats:sup>\n                    medium spiny neurons. The striatal astrocyte-converted neurons showed action potentials and synaptic events, and projected their axons to the targeted globus pallidus and substantia nigra in a time-dependent manner. Behavioral analyses found that NeuroD1 and Dlx2-treated R6\/2 mice showed a significant extension of life span and improvement of motor functions. This study demonstrates that in vivo AtN conversion may be a disease-modifying gene therapy to treat HD and other neurodegenerative disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-14855-3","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T06:04:32Z","timestamp":1582783472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3816-8891","authenticated-orcid":false,"given":"Zheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-8087","authenticated-orcid":false,"given":"Matthew","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Fei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-2097","authenticated-orcid":false,"given":"Sambangi","family":"Abhijeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"14855_CR1","doi-asserted-by":"crossref","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).","DOI":"10.1038\/nrdp.2015.5"},{"key":"14855_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME Macdonald","year":"1993","unstructured":"Macdonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons-disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"14855_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"14855_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnbeh.2015.00071","volume":"9","author":"B Reinius","year":"2015","unstructured":"Reinius, B. et al. Conditional targeting of medium spiny neurons in the striatal matrix. Front Behav. Neurosci. 9, 71 (2015).","journal-title":"Front Behav. Neurosci."},{"key":"14855_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5214\/ans.0972.7531.210308","volume":"21","author":"AA Rikani","year":"2014","unstructured":"Rikani, A. A. et al. The mechanism of degeneration of striatal neuronal subtypes in Huntington disease. Ann. Neurosci. 21, 112\u2013114 (2014).","journal-title":"Ann. Neurosci."},{"key":"14855_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JHD-160221","volume":"5","author":"C Rangel-Barajas","year":"2016","unstructured":"Rangel-Barajas, C. & Rebec, G. V. Dysregulation of corticostriatal connectivity in Huntington\u2019s disease: a role for dopamine modulation. J. Huntingt. Dis. 5, 303\u2013331 (2016).","journal-title":"J. Huntingt. Dis."},{"key":"14855_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi, M. A., Morton, A. J. & Hayden, M. R. Choosing an animal model for the study of Huntington\u2019s disease. Nat. Rev. Neurosci. 14, 708\u2013721 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"14855_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","volume":"173","author":"S Yan","year":"2018","unstructured":"Yan, S. et al. A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease. Cell 173, 989\u20131002 (2018).","journal-title":"Cell"},{"key":"14855_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang, S. H. et al. Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature 453, 921\u2013924 (2008).","journal-title":"Nature"},{"key":"14855_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma, L. et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10, 455\u2013464 (2012).","journal-title":"Cell Stem Cell"},{"key":"14855_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stemcr.2018.08.005","volume":"11","author":"M Wu","year":"2018","unstructured":"Wu, M. et al. A chemical recipe for generation of clinical-grade striatal neurons from hESCs. Stem Cell Rep. 11, 635\u2013650 (2018).","journal-title":"Stem Cell Rep."},{"key":"14855_CR12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fnins.2018.00800","volume":"12","author":"J Sassone","year":"2018","unstructured":"Sassone, J., Papadimitriou, E. & Thomaidou, D. Regenerative approaches in Huntington\u2019s disease: from mechanistic insights to therapeutic protocols. Front. Neurosci. 12, 800 (2018).","journal-title":"Front. Neurosci."},{"key":"14855_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","volume":"24","author":"J Miniarikova","year":"2017","unstructured":"Miniarikova, J. et al. AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease. Gene Ther. 24, 630\u2013639 (2017).","journal-title":"Gene Ther."},{"key":"14855_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz, H. B. et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74, 1031\u20131044 (2012).","journal-title":"Neuron"},{"key":"14855_CR15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Investig. 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Investig."},{"key":"14855_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JHD-170286","volume":"7","author":"DO Claassen","year":"2018","unstructured":"Claassen, D. O. et al. Tetrabenazine treatment patterns and outcomes for chorea associated with Huntington disease: a retrospective chart review. J. Huntingt. Dis. 7, 345\u2013353 (2018).","journal-title":"J. Huntingt. Dis."},{"key":"14855_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.06.040","volume":"12","author":"O Torper","year":"2015","unstructured":"Torper, O. et al. In vivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry. Cell Rep. 12, 474\u2013481 (2015).","journal-title":"Cell Rep."},{"key":"14855_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.stem.2013.12.001","volume":"14","author":"ZY Guo","year":"2014","unstructured":"Guo, Z. Y. et al. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer\u2019s disease model. Cell Stem Cell 14, 188\u2013202 (2014).","journal-title":"Cell Stem Cell"},{"key":"14855_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nbt.3835","volume":"35","author":"P Rivetti di Val Cervo","year":"2017","unstructured":"Rivetti di Val Cervo, P. et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model. Nat. Biotechnol. 35, 444\u2013452 (2017).","journal-title":"Nat. Biotechnol."},{"key":"14855_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ncb2843","volume":"15","author":"W Niu","year":"2013","unstructured":"Niu, W. et al. In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat. Cell Biol. 15, 1164\u20131175 (2013).","journal-title":"Nat. Cell Biol."},{"key":"14855_CR21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.stemcr.2017.04.013","volume":"8","author":"R Brulet","year":"2017","unstructured":"Brulet, R. et al. NEUROD1 instructs neuronal conversion in non-reactive astrocytes. Stem Cell Rep. 8, 1506\u20131515 (2017).","journal-title":"Stem Cell Rep."},{"key":"14855_CR22","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.1523\/JNEUROSCI.3975-14.2015","volume":"35","author":"YG Liu","year":"2015","unstructured":"Liu, Y. G. et al. Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo. J. Neurosci. 35, 9336\u20139355 (2015).","journal-title":"J. Neurosci."},{"key":"14855_CR23","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1073\/pnas.1303829110","volume":"110","author":"O Torper","year":"2013","unstructured":"Torper, O. et al. Generation of induced neurons via direct conversion in vivo. Proc. Natl Acad. Sci. USA 110, 7038\u20137043 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14855_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.neuron.2016.08.004","volume":"91","author":"HD Li","year":"2016","unstructured":"Li, H. D. & Chen, G. In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells. Neuron 91, 728\u2013738 (2016).","journal-title":"Neuron"},{"key":"14855_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-018-0087-1","volume":"557","author":"RA Barker","year":"2018","unstructured":"Barker, R. A., Gotz, M. & Parmar, M. New approaches for brain repair-from rescue to reprogramming. Nature 557, 329\u2013334 (2018).","journal-title":"Nature"},{"key":"14855_CR26","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.cell.2016.08.055","volume":"166","author":"D Srivastava","year":"2016","unstructured":"Srivastava, D. & DeWitt, N. In vivo cellular reprogramming: the next generation. Cell 166, 1386\u20131396 (2016).","journal-title":"Cell"},{"key":"14855_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.stemcr.2017.07.023","volume":"9","author":"M Pereira","year":"2017","unstructured":"Pereira, M. et al. Direct reprogramming of resident NG2 glia into neurons with properties of fast-spiking parvalbumin-containing interneurons. Stem Cell Rep. 9, 742\u2013751 (2017).","journal-title":"Stem Cell Rep."},{"key":"14855_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.stemcr.2015.03.006","volume":"4","author":"WZ Niu","year":"2015","unstructured":"Niu, W. Z. et al. SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Rep. 4, 780\u2013794 (2015).","journal-title":"Stem Cell Rep."},{"key":"14855_CR29","doi-asserted-by":"publisher","unstructured":"Long-Jiao Ge, F.-H.Y. et al. In vivo neuroregeneration to treat ischemic stroke in adult non-human primate brains through NeuroD1 AAV-based gene therapy. bioRxiv https:\/\/doi.org\/10.1101\/816066 (2019).","DOI":"10.1101\/816066"},{"key":"14855_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","volume":"84","author":"MB Victor","year":"2014","unstructured":"Victor, M. B. et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 84, 311\u2013323 (2014).","journal-title":"Neuron"},{"key":"14855_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. & Barres, B. A. Reactive astrocytes: production, function, and therapeutic potential. Immunity 46, 957\u2013967 (2017).","journal-title":"Immunity"},{"key":"14855_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski, P. I. et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 13, 584\u2013591 (2010).","journal-title":"Nat. Neurosci."},{"key":"14855_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuron.2012.11.035","volume":"77","author":"GL McKinsey","year":"2013","unstructured":"McKinsey, G. L. et al. Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons. Neuron 77, 83\u201398 (2013).","journal-title":"Neuron"},{"key":"14855_CR34","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/cercor\/bhx241","volume":"28","author":"R Pla","year":"2018","unstructured":"Pla, R. et al. Dlx1 and Dlx2 promote interneuron GABA synthesis, synaptogenesis, and dendritogenesis. Cereb. Cortex 28, 3797\u20133815 (2018).","journal-title":"Cereb. Cortex"},{"key":"14855_CR35","doi-asserted-by":"publisher","first-page":"e1000373","DOI":"10.1371\/journal.pbio.1000373","volume":"8","author":"C Heinrich","year":"2010","unstructured":"Heinrich, C. et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. Plos Biol. 8, e1000373 (2010).","journal-title":"Plos Biol."},{"key":"14855_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.4291","volume":"14","author":"N Yang","year":"2017","unstructured":"Yang, N. et al. Generation of pure GABAergic neurons by transcription factor programming. Nat. Methods 14, 621\u2013628 (2017).","journal-title":"Nat. Methods"},{"key":"14855_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fncir.2012.00052","volume":"6","author":"LJ Gentet","year":"2012","unstructured":"Gentet, L. J. Functional diversity of supragranular GABAergic neurons in the barrel cortex. Front Neural Circuits 6, 52 (2012).","journal-title":"Front Neural Circuits"},{"key":"14855_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.neuro.051508.135422","volume":"32","author":"AC Kreitzer","year":"2009","unstructured":"Kreitzer, A. C. Physiology and pharmacology of striatal neurons. Annu Rev. Neurosci. 32, 127\u2013147 (2009).","journal-title":"Annu Rev. Neurosci."},{"key":"14855_CR39","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1523\/JNEUROSCI.0434-18.2018","volume":"38","author":"J Barry","year":"2018","unstructured":"Barry, J., Akopian, G., Cepeda, C. & Levine, M. S. Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington\u2019s disease. J. Neurosci. 38, 4678\u20134694 (2018).","journal-title":"J. Neurosci."},{"key":"14855_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong, X. et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat. Neurosci. 17, 694\u2013703 (2014).","journal-title":"Nat. Neurosci."},{"key":"14855_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","volume":"509","author":"BD Paul","year":"2014","unstructured":"Paul, B. D. et al. Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease. Nature 509, 96\u2013100 (2014).","journal-title":"Nature"},{"key":"14855_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled, L. et al. Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol. Dis. 35, 319\u2013336 (2009).","journal-title":"Neurobiol. Dis."},{"key":"14855_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/cns.12839","volume":"24","author":"SM Holley","year":"2018","unstructured":"Holley, S. M. et al. Therapeutic effects of stem cells in rodent models of Huntington\u2019s disease: Review and electrophysiological findings. CNS Neurosci. Ther. 24, 329\u2013342 (2018).","journal-title":"CNS Neurosci. Ther."},{"key":"14855_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.stemcr.2017.11.005","volume":"10","author":"JC Reidling","year":"2018","unstructured":"Reidling, J. C. et al. Human neural stem cell transplantation rescues functional deficits in R6\/2 and Q140 Huntington\u2019s disease mice. Stem Cell Rep. 10, 58\u201372 (2018).","journal-title":"Stem Cell Rep."},{"key":"14855_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2016.01.012","volume":"18","author":"SA Goldman","year":"2016","unstructured":"Goldman, S. A. Stem and progenitor cell-based therapy of the central nervous system: hopes, hype, and wishful thinking. Cell Stem Cell 18, 174\u2013188 (2016).","journal-title":"Cell Stem Cell"},{"key":"14855_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41586-018-0103-5","volume":"557","author":"R Tsunemoto","year":"2018","unstructured":"Tsunemoto, R. et al. Diverse reprogramming codes for neuronal identity. Nature 557, 375\u2013380 (2018).","journal-title":"Nature"},{"key":"14855_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035\u20131041 (2010).","journal-title":"Nature"},{"key":"14855_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.stem.2011.11.015","volume":"9","author":"N Yang","year":"2011","unstructured":"Yang, N., Ng, Y. H., Pang, Z. P., Sudhof, T. C. & Wernig, M. Induced neuronal cells: how to make and define a neuron. Cell Stem Cell 9, 517\u2013525 (2011).","journal-title":"Cell Stem Cell"},{"key":"14855_CR49","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.stemcr.2018.03.007","volume":"10","author":"MM Adil","year":"2018","unstructured":"Adil, M. M. et al. hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a Huntington disease mouse model. Stem Cell Rep. 10, 1481\u20131491 (2018).","journal-title":"Stem Cell Rep."},{"key":"14855_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708\u2013721 (2012).","journal-title":"Cell"},{"key":"14855_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2015.02.006","volume":"76","author":"LN Jiang","year":"2015","unstructured":"Jiang, L. N. et al. Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells. Neurobiol. Dis. 76, 137\u2013158 (2015).","journal-title":"Neurobiol. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14855-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:51:36Z","timestamp":1670248296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14855-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14855"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14855-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gong Chen is a co-founder of NeuExcell Therapeutics Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1105"}}